Latest Observability News

Solstice Minerals has ramped up its reverse circulation drilling program at the Nanadie Copper-Gold Project in Western Australia, aiming to significantly grow its existing resource amid encouraging geological signs and a buoyant copper market.

Magnum Mining has resumed drilling at its Palmares and Azimuth rare earth projects in Brazil, advancing high-grade targets with assay results expected by the end of January.

American Tungsten & Antimony Ltd is set to submit a Notice of Intent for its first diamond drilling program at the Tennessee Mountain Tungsten Project in Nevada, aiming to validate historic high-grade mineralisation and establish a formal resource estimate.

Orthocell has reported a record $3.2 million in quarterly revenue, marking its seventh consecutive quarter of growth, driven by strong sales of its Remplir™ nerve repair product in Australia and early traction in the US market.

Terra Metals has announced a significant new discovery of platinum group metal, copper, and nickel sulfide mineralisation at the SW6 target within its Dante Project, signalling a promising expansion of its mineral resource base.

High-Tech Metals Ltd is recommencing a 3,000-metre drilling program at its Wagtail gold deposit in January 2026, aiming to refine resource data and support development studies under a strategic funding agreement.

Global X Management (AUS) Limited has announced final distribution amounts for 28 ETFs listed on the ASX AQUA Market, revealing a varied payout landscape for the period ending 31 December 2025.

Auris Minerals Limited has been queried by the ASX following a sharp rise in its share price and trading volume, with the company denying any undisclosed information behind the surge.

BlinkLab Limited has secured independent scientific validation for its smartphone-based autism diagnostic technology through publication in the prestigious journal Autism Research, marking a significant milestone ahead of its FDA regulatory trial.

Vulcan Steel has appointed Gavin Street as its new CEO and managing director, while reshuffling key board roles to maintain a majority of independent directors.

Lion Rock Minerals confirms coarse monazite crystals in residual soils at its Minta Est project, validating its exploration model and advancing its rare-earths ambitions. The milestone achievement also triggers the issuance of 500 million deferred shares to vendors.

Neurizon Therapeutics has progressed its ALS treatment NUZ-001 into critical clinical trial phases, even as the FDA declines its Fast Track Designation request pending more data.